Fortis cash-cow SRL Diagnostics hit hard by illness at parent level
But prognosis is good with improved financials, says CEO27-11-2019
27-11-2019
FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Change in Directorate
In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that Board of Directors of the Company has approved appointment of Mr. Sim Heng Joo Joe (DIN:08033111) ('Mr. Joe') as an additional director (Non-Executive and Non-Independent) of the Company with immediate effect. He will hold the office up to the next Annual General Meeting and will be regularized subject to the approval of the shareholders. He is not related to any of the existing directors. Brief Profile of Mr. Joe is attached herewith. Mr. Joe declared that, he is not debarred from accessing the capital markets and / or restrained from holding any position / office of director in a company pursuant to order of SEBI or any other such authority. This is for your information and records please.26-11-2019
No collusion with former promoters of Fortis Healthcare, says IHH
IHH acquired 31 per cent stake in Fortis last July, after a four-month bidding war involving rival hospital chains and private equity firms19-11-2019
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is in continuation of our letter ref. no. FHL/SEC/2018-19 dated December 17, 2018, in compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Kindly find attached herewith a Press Release issued by the Company, along with copy of the judgment passed by the Hon''ble Supreme Court on November 15, 2019 in the matter of Vinay Prakash Singh v. Sameer Gehlaut & Ors. We feel relevant to state that copy of the said judgement was made available in public domain and to the Company only on November 16, 2019.18-11-2019
FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is in continuation of our letter ref. no. FHL/SEC/2018-19 dated December 17, 2018, in compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Kindly find attached herewith a Press Release issued by the Company, along with copy of the judgment passed by the Hon''ble Supreme Court on November 15, 2019 in the matter of Vinay Prakash Singh v. Sameer Gehlaut & Ors. We feel relevant to state that copy of the said judgement was made available in public domain and to the Company only on November 16, 2019.18-11-2019
FORTIS HEALTHCARE LTD. - 532843 - Regulation 30- Update On Conclusion Of Litigation
This is to inform you that the Hon'ble Supreme court of India has today passed a judgement in favour of one of the wholly owned subsidiaries of the Company viz. Escort Heart Institute & Research Centre Limited (EHIRCL). The detailed disclosure is attached for your kind reference.14-11-2019
ED arrests ex-Fortis promoter Malvinder Singh, REL CMD Sunil Godhwani over money laundering charges
The Enforcement Directorate took Singh and Godhwani in its custody inside the Tihar central jail, where they are currently lodged in a case filed by the Delhi Police in relation to the alleged scam14-11-2019
Fortis Healthcare's September quarter results reinforce recovery narrative
Operating earnings saw a sharp improvement as the company benefited from higher utilization resulting in expansion in profit margins.Profit margins rose to 15.7%, up from 12.5% in June and 6.6% in the year ago quarters07-11-2019
Fortis Healthcare Ltd - 532843 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BlackRock. Inc07-11-2019
FORTIS HEALTHCARE LTD. - 532843 - Outcome of Board Meeting
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. November 6, 2019, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the quarter and period ended on September 30, 2019 along with limited review report thereon; Please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for quarter and period ended on September 30, 2019, statement of assets & liabilities' and statement of cash flow for the half year ended September 30, 2019 and a copy of the press release and investor presentation being issued in this regard. The Board Meeting commenced at 0900 Hours and concluded at 1745 Hours. This is for your information and records please.06-11-2019